A Sunshine Coast farmer was diagnosed with motor neurone disease in August this year.
She hopes to take part in phase 2 of a clinical trial which was the result of 25 years of scientific research in Queensland.
The trial will roll out nationally next year to test if a new protein-based therapy is safe and effective.
Julianne McLean knows the worst is still to come, which is why she hopes to take part in a promising clinical trial developed from 25 years of scientific research.
The 49-year-old cattle farmer from Kilkivan, about 230 kilometres north of Brisbane, was diagnosed with motor neurone disease (MND) in August.
What started as discomfort in her left leg developed into difficulty walking and foot drop, followed by spinal and voice degeneration.
Sunshine Coast University Hospital (SCUH) director of neurology Antony Winkel said MND, also known as amyotrophic lateral sclerosis (ALS), was a progressive neurological condition affecting the nerve cells in the brain and spinal cord responsible for movement.
As these motor neurons deteriorate and die, the brain can no longer send signals to the muscles, leading to muscle weakness, wasting and loss of function over time.
"Currently, we don't have a great understanding of what causes it," Dr Winkel said.
